title: Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
authors.affiliation: Department of Surgery, Klinikum Grosshadern, Munich, FRG.
authors.forename: W D
authors.initials: WD
authors.lastname: Illner
authors.forename: J
authors.initials: J
authors.lastname: Theodorakis
authors.forename: D
authors.initials: D
authors.lastname: Abendroth
authors.forename: S
authors.initials: S
authors.lastname: Schleibner
authors.forename: M
authors.initials: M
authors.lastname: Stangl
authors.forename: R
authors.initials: R
authors.lastname: Landgraf
authors.forename: W
authors.initials: W
authors.lastname: Land
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D016035:Pancreas Transplantation / Q000276:immunology*; D013256:Steroids / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D016853:Muromonab-CD3; D013256:Steroids; D001379:Azathioprine